TGA Approval

UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial (446050)

ARTG ID

446050

ARTG Name

UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial

Sponsor

Amgen Australia Pty Ltd

ARTG Date

March 12, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

Ingredient Name

inebilizumab

Empowering clinical research with data-driven insights and AI-powered tools.

UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial (446050) - TGA 批准文号 | MedPath